A Phase I/II Clinical Trial Evaluating the Safety and Immunogenicity of LC16m8, a Modified Vaccinia Vaccine, in Healthy Volunteers

Grants and Contracts Details

StatusFinished
Effective start/end date9/1/04 → 10/31/13

Funding

  • VaxGen Inc: $796,459.00